Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?

Richard J. Johnson(Providence Sacred Heart Medical Center), Duk‐Hee Kang(Providence Sacred Heart Medical Center), Daniel I. Feig(Providence Sacred Heart Medical Center), Salah D. Kivlighn(Providence Sacred Heart Medical Center), John Kanellis(Providence Sacred Heart Medical Center), Susumu Watanabe(Providence Sacred Heart Medical Center), Katherine R. Tuttle(Providence Sacred Heart Medical Center), Bernardo Rodríguez‐Iturbe(Providence Sacred Heart Medical Center), Jaime Herrera-Acosta(Providence Sacred Heart Medical Center), Marilda Mazzali(Providence Sacred Heart Medical Center)
Hypertension
April 22, 2003
Cited by 1,366Open Access
Full Text

Abstract

Hyperuricemia is associated with hypertension, vascular disease, renal disease, and cardiovascular events. In this report, we review the epidemiologic evidence and potential mechanisms for this association. We also summarize experimental studies that demonstrate that uric acid is not inert but may have both beneficial functions (acting as an antioxidant) as well as detrimental actions (to stimulate vascular smooth muscle cell proliferation and induce endothelial dysfunction). A recently developed experimental model of mild hyperuricemia also provides the first provocative evidence that uric acid may have a pathogenic role in the development of hypertension, vascular disease, and renal disease. Thus, it is time to reevaluate the role of uric acid as a risk factor for cardiovascular disease and hypertension and to design human studies to address this controversy.


Related Papers

No related papers found

Powered by citation graph analysis